Core Points - The company, New Tian Pharmaceutical, announced that its wholly-owned subsidiary, Shanghai Shuo Fang Pharmaceutical Technology Co., Ltd., has received a patent certificate from the National Intellectual Property Administration for an invention titled "A Method for Detecting the Fingerprint Spectrum of Ginkgo Biloba Decoction and Its Fingerprint Spectrum" [2] Summary by Category - **Company Announcement** - New Tian Pharmaceutical has successfully obtained a patent for a new method related to Ginkgo Biloba [2] - **Intellectual Property** - The patent is aimed at enhancing the detection and analysis of Ginkgo Biloba decoction, which may provide a competitive edge in the pharmaceutical industry [2]